Ruggiero, Angelo

Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: Results from an Italian 28-week retrospective study

Megna, M., Tommasino, N., Potestio, L., Battista, T., Ruggiero, A., Noto, M., Fabbrocini, G., & Genco, L. (2022) · Journal of Dermatological Treatment

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 90

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review

Ruggiero, A., Martora, F., Fabbrocini, G., Villani, A., Marasca, C., Megna, M., Fornaro, L., Comune, R., & Potestio, L. (2022) · Clinical, Cosmetic and Investigational Dermatology

Telemedicine and Telehealth ImplementationDermatological and COVID-19 studies

Cited by 46